Spinal cord injury is a complex condition. Future research may show whether stem cells in combination with other therapies could be part of a new paradigm of treatment to improve outcomes for ...

InVivo Therapeutics is a research and clinical-stage biotechnology company focused on the development of technologies for the treatment of spinal cord injuries ... of a stem cell–Neuro-Spinal ...

“This type of cellular therapy ... the differentiation of stem cells over time is “impressive,” as is their ability to make connections in the monkeys’ central nervous systems, but more work needs to ...

Neural stem cell transplantation is an emerging treatment for various neurological ... cell transplantation for chronic thoracic spinal cord injury, Cell Reports Medicine (2024).

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

Three of the four patients were deemed by examiners to have very slight improvements in sensation and muscle movement. Severe spinal injuries can have devastating consequences, often leaving patients ...

Multiple babies have been born after receiving the world’s first spina bifida treatment ... The stem cell patch was placed directly over the exposed spinal cord of the fetus.

Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...